FDA Clearance Tracker · P180046-S056
Axonics Sacral Neuromodulation System
Last checked: Nov 20, 2026Latest source record: Jan 30, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jan 30, 2023
Approved
Time to decision
248 days
Received May 27, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P180046-S056
- Device name
- Axonics Sacral Neuromodulation System
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marlborough, MA
- Received
- May 27, 2022
- Decided
- Jan 30, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P180046
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
Approval of a rechargeable Neurostimulator, model 5101 and updated software for the Clinician Programmer, model 2501.
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.